- Joined
- Dec 3, 2017
- Messages
- 26,290
- Reaction score
- 16,771
- Gender
- Male
- Political Leaning
- Progressive
Drug company announces new version of insulin at half the price | TheHill
The drug company Eli Lilly on Monday announced that it is introducing a cheaper version of its insulin that will sell at half the price.
The move comes in response to intense scrutiny of drug prices and particularly insulin, a decades-old drug that people with diabetes need that has seen huge price spikes in recent years.
============================================
Lilly for many years extracted insulin from pig pancreas, a messy & waste-intensive process. Despite being a very conservative company located in the heart of a very conservative state (IN), they were one of the first companies to switch to the use of genetic engineering to produce insulin by fermenting recombinant bacteria into which copes of the insulin genes had been spliced.
'In October 1982, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's Humulin, the first human insulin for diabetes treatment created using recombinant DNA technology. ... It was around the same time, luckily, that recombinant DNA technology or genetic engineering, became available.'
The drug company Eli Lilly on Monday announced that it is introducing a cheaper version of its insulin that will sell at half the price.
The move comes in response to intense scrutiny of drug prices and particularly insulin, a decades-old drug that people with diabetes need that has seen huge price spikes in recent years.
============================================
Lilly for many years extracted insulin from pig pancreas, a messy & waste-intensive process. Despite being a very conservative company located in the heart of a very conservative state (IN), they were one of the first companies to switch to the use of genetic engineering to produce insulin by fermenting recombinant bacteria into which copes of the insulin genes had been spliced.
'In October 1982, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's Humulin, the first human insulin for diabetes treatment created using recombinant DNA technology. ... It was around the same time, luckily, that recombinant DNA technology or genetic engineering, became available.'